Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Global strategies are required to cure and eliminate HBV infection
Peter Revill, Barbara Testoni, Stephen Locarnini, et al.
Nature Reviews Gastroenterology & Hepatology (2016) Vol. 13, Iss. 4, pp. 239-248
Closed Access | Times Cited: 149

Showing 1-25 of 149 citing articles:

Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
Brittney S Sheena, Lindsey Hiebert, Hannah Han, et al.
˜The œLancet. Gastroenterology & hepatology (2022) Vol. 7, Iss. 9, pp. 796-829
Open Access | Times Cited: 486
Immune checkpoint blockade in infectious diseases
Michelle Wykes, Sharon R. Lewin
Nature reviews. Immunology (2017) Vol. 18, Iss. 2, pp. 91-104
Open Access | Times Cited: 473
A global scientific strategy to cure hepatitis B
Peter Revill, Francis V. Chisari, Joan M. Block, et al.
˜The œLancet. Gastroenterology & hepatology (2019) Vol. 4, Iss. 7, pp. 545-558
Open Access | Times Cited: 418
The role of quantitative hepatitis B surface antigen revisited
Markus Cornberg, Vincent Wai‐Sun Wong, Stephen Locarnini, et al.
Journal of Hepatology (2016) Vol. 66, Iss. 2, pp. 398-411
Closed Access | Times Cited: 323
Hepatitis B Virus X Protein Promotes Degradation of SMC5/6 to Enhance HBV Replication
Christopher M. Murphy, Yanping Xu, Feng Li, et al.
Cell Reports (2016) Vol. 16, Iss. 11, pp. 2846-2854
Open Access | Times Cited: 273
Global burden of hepatitis B virus: current status, missed opportunities and a call for action
Yao‐Chun Hsu, Daniel Q. Huang, Mindie H. Nguyen
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 8, pp. 524-537
Closed Access | Times Cited: 253
HIV-hepatitis B virus coinfection
Kasha P. Singh, Megan Crane, Jennifer Audsley, et al.
AIDS (2017) Vol. 31, Iss. 15, pp. 2035-2052
Open Access | Times Cited: 206
Disparities in liver cancer occurrence in the United States by race/ethnicity and state
Farhad Islami, Kimberly D. Miller, Rebecca L. Siegel, et al.
CA A Cancer Journal for Clinicians (2017) Vol. 67, Iss. 4, pp. 273-289
Open Access | Times Cited: 201
Recapitulation of hepatitis B virus–host interactions in liver organoids from human induced pluripotent stem cells
Yunzhong Nie, Yun‐Wen Zheng, Kei Miyakawa, et al.
EBioMedicine (2018) Vol. 35, pp. 114-123
Open Access | Times Cited: 152
The evolution and clinical impact of hepatitis B virus genome diversity
Peter Revill, Thomas Tu, Hans Netter, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 17, Iss. 10, pp. 618-634
Closed Access | Times Cited: 136
TLR7 Agonist Increases Responses of Hepatitis B Virus–Specific T Cells and Natural Killer Cells in Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues
Carolina Boni, Andrea Vecchi, Marzia Rossi, et al.
Gastroenterology (2018) Vol. 154, Iss. 6, pp. 1764-1777.e7
Closed Access | Times Cited: 130
Pyroptosis in Liver Disease: New Insights into Disease Mechanisms
Jiali Wu, Su Lin, Bo Wan, et al.
Aging and Disease (2019) Vol. 10, Iss. 5, pp. 1094-1094
Open Access | Times Cited: 129
Lymphocytes transiently expressing virus-specific T cell receptors reduce hepatitis B virus infection
Janine Kah, Sarene Koh, Tassilo Volz, et al.
Journal of Clinical Investigation (2017) Vol. 127, Iss. 8, pp. 3177-3188
Open Access | Times Cited: 99
A global investment framework for the elimination of hepatitis B
Jessica Howell, Alisa Pedrana, Sophia Schroeder, et al.
Journal of Hepatology (2020) Vol. 74, Iss. 3, pp. 535-549
Open Access | Times Cited: 71
Pathway to global elimination of hepatitis B: HBV cure is just the first step
Jessica Howell, Chris Seaman, Jack Wallace, et al.
Hepatology (2023) Vol. 78, Iss. 3, pp. 976-990
Open Access | Times Cited: 23
A research agenda for curing chronic hepatitis B virus infection
Harvey J. Alter, Timothy M. Block, Nathaniel Brown, et al.
Hepatology (2017) Vol. 67, Iss. 3, pp. 1127-1131
Open Access | Times Cited: 81
HIV–HBV and HIV–HCV Coinfection and Liver Cancer Development
Jianming Hu, Kuancheng Liu, Jun Luo
Cancer treatment and research (2018), pp. 231-250
Open Access | Times Cited: 78
Advances with using CRISPR/Cas-mediated gene editing to treat infections with hepatitis B virus and hepatitis C virus
Buhle Moyo, Kristie Bloom, Tristan Scott, et al.
Virus Research (2017) Vol. 244, pp. 311-320
Closed Access | Times Cited: 64
Increased NK Cell Function After Cessation of Long-Term Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Is Associated With Liver Damage and HBsAg Loss
Christine L. Zimmer, Franziska Rinker, Christoph Höner zu Siederdissen, et al.
The Journal of Infectious Diseases (2018) Vol. 217, Iss. 10, pp. 1656-1666
Open Access | Times Cited: 64
A Combination of Human Broadly Neutralizing Antibodies against Hepatitis B Virus HBsAg with Distinct Epitopes Suppresses Escape Mutations
Qiao Wang, Eleftherios Michailidis, Yingpu Yu, et al.
Cell Host & Microbe (2020) Vol. 28, Iss. 2, pp. 335-349.e6
Open Access | Times Cited: 61
HBV replication inhibitors
Claire Pierra Rouvière, Cyril B. Dousson, John E. Tavis
Antiviral Research (2020) Vol. 179, pp. 104815-104815
Open Access | Times Cited: 50
2020 position statement and recommendations of the European Liver and Intestine Transplantation Association (ELITA): management of hepatitis B virus‐related infection before and after liver transplantation
Christophe Duvoux, L Belli, James Fung, et al.
Alimentary Pharmacology & Therapeutics (2021) Vol. 54, Iss. 5, pp. 583-605
Closed Access | Times Cited: 43
Discovery of a first-in-class orally available HBV cccDNA inhibitor
Li Wang, Qihui Zhu, Jitao David Zhang, et al.
Journal of Hepatology (2022) Vol. 78, Iss. 4, pp. 742-753
Closed Access | Times Cited: 34
Molecular insights into Spindlin1-HBx interplay and its impact on HBV transcription from cccDNA minichromosome
Wei Liu, Qiyan Yao, Xiaonan Su, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 19
Current Challenges and Future Perspectives of Diagnosis of Hepatitis B Virus
Manoj Kumar, Sangeeta Pahuja, Prashant Khare, et al.
Diagnostics (2023) Vol. 13, Iss. 3, pp. 368-368
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top